Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
Introduction The rising burden of drug resistance is a major challenge to the global fight against malaria. We estimated national Plasmodium falciparum resistance to sulfadoxine-pyrimethamine (SP) across Africa, from 2000 to 2020.Methods We assembled molecular, clinical and endemicity data covering...
Main Authors: | Floriano Amimo, Anthony Magit, Jahit Sacarlal, Ben Lambert, Kenji Shibuya, Masahiro Hashizume |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/5/11/e003217.full |
Similar Items
-
Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
by: Aleisha R. Brock, et al.
Published: (2017-05-01) -
Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
by: Ahmed Elderderi S, et al.
Published: (2005-09-01) -
The role of mutations in uncomplicated Plasmodium falciparum malaria and sulfadoxine pyrimethamine efficacy in Mpumalanga Province, South Africa.
by: Mngomezulu, Nicros Magangeni
Published: (2006) -
A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa
by: Floriano Amimo, et al.
Published: (2021-04-01) -
Comparative efficacy of chloroquine and pyrimethamine-sulfadoxine versus artemether and pyrimethamine-sulfadoxine in the treatment of uncomplicated falciparum malaria in children
by: Femmy Tambajong, et al.
Published: (2016-10-01)